The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling
NCT03913845 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2026-04-30
Summary
Stress urinary incontinence affects millions of women worldwide and has a profound impact on the quality of life of older individuals, their subjective health status, levels of depression and need for care. Midurethral sling placement was introduced in 1995 and remains the current gold standard for surgical management of SUI. Although the advantages of midurethral sling surgery include its high success and minimally invasive approach, approximately 10-50% of women experience acute postoperative urinary retention and are subsequently sent home with an indwelling foley catheter or clean intermittent self catheterization. Urinary retention is anxiety provoking for most patients and adds morbidity, cost, and increased utilization of healthcare resources. Additionally, catheterization of the urinary tract results in increased risk of urinary tract infection and potential need for antibiotics.
Several recent studies have reported varying rates of postoperative voiding trial success depending on the type of local anesthetic used for hydrodissection; however the data is sparse and invites a more thorough investigation. Furthermore, to the investigators knowledge, no studies have systematically explored dosage or type of agent used intraoperatively on postoperative voiding function. Based on the preliminary data, the investigators hypothesize that patients receiving normal saline compared to a local anesthetic (e.g., lidocaine) will have a reduction in duration of postoperative urinary retention following retropubic midurethral sling placement.
Conditions
- Stress Urinary Incontinence
Interventions
- DRUG
-
lidocaine with epinephrine
One of the most commonly used local anesthetic agents in surgical practice is lidocaine. Lidocaine as a local anesthetic is characterized by a rapid onset of action (typically within 2-5 minutes of injection) and intermediate duration of efficacy and thus is often favored in the outpatient setting for pre-incisional injections. Of note, however, its effects general only last up to 2 hours. Epinephrine (adrenaline) vasoconstricts arteries, delaying the resorption of lidocaine, and thus almost doubles the duration of anesthesia.
- DRUG
-
Normal saline with epinephrine
Several mechanisms could explain the inability to void postoperatively, including nerve conduction impairment from anesthesia. Multiple studies have investigated the use of various types of anesthesia and downstream effects on postoperative urinary retention. It is postulated that denervating the regional pelvic nerves for pain control may lead to denervation of the bladder for a transient period of time, block both the afferent and efferent pathways of the voiding mechanism, affect the urethral retro-resistance pressure and impact urethral length thereby contributing to voiding dysfunction postoperatively. The use of normal saline in this setting may have a reduction in rates and duration of postoperative urinary retention following retropubic midurethral sling placement.
Sponsors & Collaborators
-
AHN Research Institute
collaborator UNKNOWN -
West Penn Allegheny Health System
lead OTHER
Principal Investigators
-
Lindsay Turner, MD · Department of Obstetrics and Gynecology, Allegheny Health Network
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-25
- Primary Completion
- 2024-11-14
- Completion
- 2024-11-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence
NCT00475839 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Voiding Trials After Midurethral Sling for Stress Incontinence
NCT02400034 ·Status: COMPLETED ·Phase: NA
-
Changes in the Bladder Micro-environment Following Midurethral Sling Surgery for Stress Urinary Incontinence
NCT03942549 ·Status: UNKNOWN
-
Laparoscopic Burch Colposuspension Versus Midurethral Sling for Treatment of Female Stress Urinary Incontinence a Randomized Controlled Trial
NCT04775186 ·Status: UNKNOWN ·Phase: NA
-
Changes in ALPP in Women With SUI Following Air Instillation
NCT02113670 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
NCT02131311 ·Status: COMPLETED ·Phase: NA
-
Long-term Evaluation of the I-STOP Sling in Stress Urinary Incontinence Treatment
NCT06665698 ·Status: NOT_YET_RECRUITING
-
The Effect of Pudendal Blocks on Voiding Dysfunction Following Slings
NCT03353714 ·Status: COMPLETED ·Phase: NA
-
An Investigation With an Intra-vaginal Device for Stress Urinary Incontinence
NCT03186651 ·Status: COMPLETED ·Phase: NA
-
Vaginal Prolapse Surgery Accompanied by Mid Urethral Sling Versus no Sling for Reduction of Postoperative Incontinence
NCT04251923 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Transobturator Sling Compared With Single-incision Mini-sling for the Treatment of Stress Urinary Incontinence
NCT02540525 ·Status: COMPLETED ·Phase: NA
-
Quality-of-Life Outcomes After Autologous Fascial Sling and TVT: a Prospective Randomized Trial
NCT00565838 ·Status: COMPLETED
-
Female Sling Procedure
NCT04571346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence
NCT00492596 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Mini Sling Versus Transobturator Tape in Surgical Management of Women With Stress Urinary Incontinence
NCT06334848 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women
NCT02407145 ·Status: COMPLETED
-
Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence
NCT02263534 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
NCT02160314 ·Status: COMPLETED ·Phase: NA
-
Mid-Urethral Sling Tensioning Trial
NCT02480231 ·Status: COMPLETED ·Phase: NA
-
Value of Urodynamics Prior to Stress Incontinence Surgery 2
NCT00814749 ·Status: UNKNOWN ·Phase: NA
-
Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence
NCT00688298 ·Status: COMPLETED ·Phase: NA
-
Assessment of Voiding After Sling
NCT01343784 ·Status: COMPLETED ·Phase: NA
-
Does Bladder Instillation Reduce Time to Discharge After Sling Surgery
NCT02277288 ·Status: RECRUITING ·Phase: NA
-
The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)
NCT02806713 ·Status: COMPLETED ·Phase: PHASE3
-
Pessary Experience Study
NCT06021769 ·Status: RECRUITING